Whether millions gain access to breakthrough anti-obesity treatments may depend on Kennedy, Mehmet Oz and other key players ...
Kennedy Jr., who has been tapped by Trump to lead the HHS, has been critical of Ozempic and other weight loss drugs.
President-elect Donald J. Trump is set to nominate Robert F. Kennedy Jr. to lead the Health and Human Services Department, ...
The Biden administration proposed expanding coverage of weight loss medication to Medicaid and Medicare recipients. RFK Jr.
The growth of weight loss drugs and Robert F. Kennedy Jr.’s push to improve Americans’ diets won’t stop people from snacking ...
Robert F. Kennedy Jr.: "No, this isn't. You know, I saw this headline yesterday, and I need to look at the methodology of that study, because I don't believe it. The EU is, right now, investigating ...
Robby Soave and Niall Stanage weigh in on how Robert F. Kennedy Jr. will impact the booming popularity of weight loss drugs.
Investors are fearful RFK Jr.'s critical stance on weight loss drugs could impact pricing or Medicare coverage, but BMO says ...
Kennedy Jr.'s proposed appointment to lead the US Department ... as long-lasting shortages of drugs like Ozempic come to an end. Kennedy tore into Ozempic maker Novo Nordisk in a September 26 ...
Millions of obese Americans would get access to popular weekly injectables that would help them shed pounds quickly if a $35 ...
Kennedy, who as Trump’s nominee for HHS secretary is subject to Senate confirmation, has railed against the drugs ...
Kennedy Jr. are both pushing for Americans to change ... in the US has used one of the popular GLP-1 medications, including Ozempic and Wegovy. Millions more senior citizens and lower-income ...